Men's health
screening & prevention

Why early detection matters

Most urological cancers — prostate, kidney, and testicular — are silent in their early stages. There are no symptoms until the disease has often progressed beyond the point where the simplest, least invasive treatments are possible. This is why regular screening is one of the most important decisions a man can make for his long-term health.

When detected early, prostate cancer can be managed with active surveillance — no treatment at all — or cured with a single, minimally invasive procedure. Kidney tumours found incidentally on ultrasound can often be removed with a kidney-sparing operation. Testicular cancer caught early has a cure rate exceeding 95%.

A comprehensive urological check requires nothing more than a blood test and an ultrasound. It is fast, non-invasive, and can provide genuine reassurance — or prompt timely action when it matters most.

The PSA screening programme

Austria has an established, funded early-detection programme for prostate cancer. It is based on a PSA blood test — a simple measurement of prostate-specific antigen in the bloodstream. PSA is produced by all prostate cells, but cancer cells release significantly more, causing the level to rise. A single blood draw, combined with a clinical consultation, is all that is required.

Screening is recommended from age 45 for men at standard risk. Men with a first-degree relative (father or brother) who had prostate cancer should begin at age 40, as their lifetime risk is approximately doubled. Men over 70 should discuss the screening interval individually with their physician.

An elevated PSA does not mean cancer — it is an indicator that guides further evaluation. If the value is raised, the next steps are an MRI of the prostate and, if needed, a targeted fusion biopsy. This modern pathway avoids unnecessary procedures and focuses investigation only where it is genuinely warranted.

What we screen for

01.
Prostate cancer

The most common cancer in men. Annual PSA blood test from age 45 (age 40 with family history). A rising PSA or abnormal value triggers MRI and targeted biopsy only if necessary. When detected at an early, organ-confined stage, prostate cancer is highly curable — or can simply be monitored without any treatment.

02.
Kidney cancer

Kidney tumours rarely cause symptoms until they are large. The majority of kidney cancers today are discovered incidentally — on an abdominal ultrasound performed for another reason. Including a kidney ultrasound in the annual check costs nothing extra and can catch a tumour when it is still small, organ-confined, and treatable with a kidney-sparing operation.

03.
Testicular cancer

The most common solid tumour in men aged 15–40. Regular self-examination and scrotal ultrasound allow detection at an early stage, when cure rates exceed 95%. Tumour markers (AFP, beta-HCG, LDH) in the blood complement the ultrasound and provide important staging information. Awareness and early presentation are the single most important factors in outcome.